Research programme: autologous cultured chondrocytes - Advanced Tissue Sciences

Drug Profile

Research programme: autologous cultured chondrocytes - Advanced Tissue Sciences

Alternative Names: Cartilage replacement - Advanced Tissue Sciences; Liquid cartilage replacement - Advanced Tissue Sciences; NeoCyte™

Latest Information Update: 25 Aug 2006

Price : $50

At a glance

  • Originator Advanced Tissue Sciences [CEASED]
  • Class Cell therapies
  • Mechanism of Action Cartilage replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Knee injuries

Most Recent Events

  • 25 Aug 2006 Discontinued - Preclinical for Knee injuries in USA (Injection)
  • 21 Nov 2002 Advanced Tissue Sciences has decided to liquidate its business
  • 18 Oct 2002 Advanced Tissue Sciences has filed under Chapter 11 of the US Bankruptcy Code
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top